315 related articles for article (PubMed ID: 28181147)
1. A Clinic-based Survey of Clinical Characteristics and Practice Pattern of Dry Eye in Japan.
Kawashima M; Yamada M; Suwaki K; Shigeyasu C; Uchino M; Hiratsuka Y; Yokoi N; Tsubota K;
Adv Ther; 2017 Mar; 34(3):732-743. PubMed ID: 28181147
[TBL] [Abstract][Full Text] [Related]
2. Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.
Yamane M; Ogawa Y; Fukui M; Kamoi M; Saijo-Ban Y; Yaguchi S; Mukai S; Kawakita T; Simmura S; Tsubota K
Optom Vis Sci; 2015 Apr; 92(4 Suppl 1):S25-32. PubMed ID: 25785527
[TBL] [Abstract][Full Text] [Related]
3. Comparing two mucin secretagogues for the treatment of dry eye disease: a prospective randomized crossover trial.
Jin Y; Seo KY; Kim SW
Sci Rep; 2024 Jun; 14(1):13306. PubMed ID: 38858411
[TBL] [Abstract][Full Text] [Related]
4. The Efficacy of Diquafosol Ophthalmic Solution in Non-Sjögren and Sjögren Syndrome Dry Eye Patients Unresponsive to Artificial Tear.
Jeon HS; Hyon JY
J Ocul Pharmacol Ther; 2016 Sep; 32(7):463-8. PubMed ID: 27294831
[TBL] [Abstract][Full Text] [Related]
5. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
Hwang HS; Sung YM; Lee WS; Kim EC
Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial.
Park CH; Lee HK; Kim MK; Kim EC; Kim JY; Kim TI; Kim HK; Song JS; Yoon KC; Lee DH; Chung TY; Choi CY; Kim HS
BMC Ophthalmol; 2019 Jun; 19(1):131. PubMed ID: 31208393
[TBL] [Abstract][Full Text] [Related]
7. A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye.
Kinoshita S; Oshiden K; Awamura S; Suzuki H; Nakamichi N; Yokoi N;
Ophthalmology; 2013 Jun; 120(6):1158-65. PubMed ID: 23490326
[TBL] [Abstract][Full Text] [Related]
8. Diquafosol ophthalmic solution 3 %: a review of its use in dry eye.
Keating GM
Drugs; 2015 May; 75(8):911-22. PubMed ID: 25968930
[TBL] [Abstract][Full Text] [Related]
9. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial.
Park DH; Chung JK; Seo DR; Lee SJ
Am J Ophthalmol; 2016 Mar; 163():122-131.e2. PubMed ID: 26685791
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with diquafosol tetrasodium and sodium hyaluronate in patients with dry eye after laser in situ keratomileusis.
Toda I; Ide T; Fukumoto T; Ichihashi Y; Tsubota K
Am J Ophthalmol; 2014 Mar; 157(3):616-22.e1. PubMed ID: 24528935
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Topical 3% Diquafosol Ophthalmic Solution for the Treatment of Multifactorial Dry Eye Disease: Meta-Analysis of Randomized Clinical Trials.
Nam K; Kim HJ; Yoo A
Ophthalmic Res; 2019; 61(4):188-198. PubMed ID: 30654362
[TBL] [Abstract][Full Text] [Related]
12. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.
Shigeyasu C; Yamada M; Akune Y; Tsubota K
Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease.
Mun Y; Kwon JW; Oh JY
BMC Ophthalmol; 2018 Sep; 18(1):237. PubMed ID: 30185156
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eye.
Koh S; Ikeda C; Takai Y; Watanabe H; Maeda N; Nishida K
Jpn J Ophthalmol; 2013 Sep; 57(5):440-6. PubMed ID: 23740285
[TBL] [Abstract][Full Text] [Related]
15. Effects of Diquafosol Ophthalmic Solution on Quality of Life in Dry Eye Assessed Using the Dry Eye-Related Quality-of-Life Score Questionnaire: Effectiveness in Patients While Reading and Using Visual Display Terminals.
Utsunomiya T; Kawahara A; Hanada K; Yoshida A
Cornea; 2017 Aug; 36(8):908-914. PubMed ID: 28542084
[TBL] [Abstract][Full Text] [Related]
16. Prospective, Multicenter, Cross-Sectional Survey on Dry Eye Disease in Japan.
Shimazaki J; Nomura Y; Numa S; Murase Y; Kakinoki K; Abe F; Kato Y; Okabe H; Kishimoto H; Yamada Y
Adv Ther; 2020 Jan; 37(1):316-328. PubMed ID: 31728824
[TBL] [Abstract][Full Text] [Related]
17. Diquafosol ophthalmic solution for dry eye treatment.
Nakamura M; Imanaka T; Sakamoto A
Adv Ther; 2012 Jul; 29(7):579-89. PubMed ID: 22843206
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Rebamipide Instillation for Contact Lens Discomfort With Dry Eye.
Igarashi T; Kobayashi M; Yaguchi C; Fujimoto C; Suzuki H; Takahashi H
Eye Contact Lens; 2018 Nov; 44 Suppl 2(2):S137-S142. PubMed ID: 29135738
[TBL] [Abstract][Full Text] [Related]
19. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S
Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Topical Cyclosporine and Diquafosol Treatment in Dry Eye.
Yang JM; Choi W; Kim N; Yoon KC
Optom Vis Sci; 2015 Sep; 92(9):e296-302. PubMed ID: 26107023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
